YWYang Wang

Yang Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yang Wang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Gao

    Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.

    3 shared publications
  • Luca Maccioni

    Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA

    3 shared publications
  • Dechun Feng

    Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA

    2 shared publications
  • Yukun Guan

    Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA

    2 shared publications
  • Andrew Cameron

    Surgery - Division of Transplant Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    1 shared publication
  • Brandon Peiffer

    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    1 shared publication

Latest Publications

  • Opposite regulation of intestinal and intrahepatic CD8 + T cells controls alcohol-associated liver disease progression

    by Luca Maccioni, Yukun Guan, Mariia Kim, Maria A Parra, Brandon Peiffer, Yaojie Fu, Yang Wang, Yu-Hong Lin, Bryan Mackowiak, Dechun Feng, et al.

    Background: Gut-liver crosstalk plays an important role in alcohol-associated liver disease (ALD) pathogenesis; but underlying mechanisms remain obscure. Objective: We examined the regulation of intestinal and intrahepatic CD8 + T lymphocytes and their contribution to ALD. Design: ALD patients were recruited for evaluation of intestinal and liver T cells. Single-cell RNA sequencing (scRNA seq) was performed to analyse intrahepatic and peripheral T cells in ALD. Wildtype, CD8-specific Bcl2 transgenic ( Cd8 Bcl-2 ), and Cd8 −/− mice were subjected to chronic-plus-binge ethanol feeding. Results: In ALD patients, duodenal CD8 + T cells were selectively reduced and negatively correlated with liver injury and bacterial translocation markers, while intrahepatic CD8 + T cells were markedly increased. ScRNA seq analysis of ALD patient livers revealed several populations of CD8 + T cells expressing activation and survival genes (eg, Bcl2 ). Transcriptomics and functional studies revealed a key role of prosurvival BCL2 in this opposite regulation of CD8 + T cells. Mechanistically, chronic-plus-binge ethanol feeding reduced CD8 + T cells specifically in the duodenum where ethanol levels are high. Inducing BCL2 in CD8 + T cells reversed ethanol-induced loss of duodenal CD8 + T cells, improved gut barrier function and ameliorated ALD, while CD8 deficiency was linked to enhanced neutrophil and macrophage infiltration in the liver, exacerbating ALD in mice. Conclusions: ALD is associated with loss of duodenal CD8 + T cells but elevation of intrahepatic CD8 + T cells, which aggravates and ameliorates ALD, respectively. Restoration of survival and functions of intestinal and intrahepatic CD8 + T cells may represent a novel therapeutic strategy for ALD patients.


  • Open Access

    Characterisation of macrophages in healthy and diseased livers in mice: identification of necrotic lesion-associated macrophages

    by Dechun Feng, Yukun Guan, Yang Wang, Luca Maccioni, Bryan Mackowiak, Bin Gao

    Background: Healthy livers contain a large number of resident macrophages named Kupffer cells (KCs), which are partially replaced by infiltrating monocyte-derived macrophages (MoMFs) during acute or chronic liver injury. Despite extensive research, understanding macrophage heterogeneity, spatial distribution and interactions with other cells within the liver remains challenging. Methods: This study employs sequential multiplex immunofluorescence staining, advanced image analysis and single-cell RNA sequencing (scRNA-seq) analysis to characterise macrophages in both healthy and diseased livers in mice. Results: Our data revealed that liver KCs made up more than 80% of total immune cells in healthy mouse livers, while massive amounts of MoMFs infiltrated into the livers after acute and chronic liver injury. KCs were more abundant and larger in Zones 1 and 2 compared with Zone 3 in healthy livers. Zone 1 KCs exhibited higher phagocytic activity than Zone 2/3 KCs and MoMFs. We simultaneously evaluated cell proliferation and apoptosis on one slide and found that proliferation and apoptosis of KCs and MoMFs significantly increased in acutely injured livers. We also performed scRNA-seq to investigate liver macrophage gene expression in naïve and concanavalin A (ConA)-treated mice. MoMF clusters expanded following ConA treatment, while KCs remained stable. Macrophages were divided into distinct subtypes, including C1q+ MoMFs, with differential expression of genes like Trem2, Spp1, Fabp5 and Gpnmb. Newly recruited C1q− MoMFs expressed high levels of Lyz and Ccr2, while Itgax (Cd11c)+ MoMFs expressed endothelin converting enzyme 1 (Ece1), a gene encoding ECE1 enzyme that activates endothelin to promote hepatic stellate cell contraction and necrotic lesion resolution. By immunostaining analysis of the proteins encoded by these signature genes, we identified several populations of MoMFs that were mainly located surrounding the necrotic lesion area and expressed various proteins that are involved in dead cell debris clearance. Conclusion: We developed a robust framework for studying liver macrophages in vivo, offering insights into their roles in host defence and liver injury/repair. We identified several populations of MoMFs that surround necrotic lesion areas and express proteins that promote dead cell debris clearance. These necrotic lesion-associated macrophages likely play key roles in promoting necrotic lesion resolution.


  • Open Access

    New therapeutic target for alcohol-associated hepatitis (AH): AH-associated IL-8+ neutrophils

    by Yukun Guan, Dechun Feng, Luca Maccioni, Yang Wang, Bin Gao

    Alcohol-associated liver disease (ALD) is one of the leading chronic liver diseases worldwide, encompassing a spectrum of conditions from simple steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma.1 Histologically, alcohol-associated steatohepatitis (ASH) is characterised by lipid accumulation in hepatocytes, hepatocellular damage, ballooning of hepatocytes, formation of Mallory-Denk bodies, inflammation and pericellular fibrosis.1 Over the past several decades, research has elucidated key molecular mechanisms underlying ALD, such as ethanol-induced hepatotoxicity, oxidative stress, endoplasmic reticulum stress and organ–organ crosstalk pathways like the gut-liver and adipose tissue-liver axes.2 Patients with underlying chronic ALD, particularly those with recent episodes of excessive drinking, are at risk of developing acute alcohol-associated hepatitis (AH), a condition characterised by severe clinical symptoms, including jaundice.3 Severe AH (sAH) is commonly linked to alcohol-associated cirrhosis (AC) and carries a high short-term mortality rate. Due to the limited availability of effective pharmacological therapies, early liver transplantation is frequently required as a life-saving intervention.3 Identifying molecular mechanisms driving AH progression and liver failure is thus essential for developing targeted therapies for this life-threatening disease. AH, first described in 1961, is recognised as an acute inflammatory liver disease characterised by extensive inflammatory cell infiltration.4 Currently, AH is recognised as a form of acute-on-chronic liver injury involving various types of immune cells, including macrophages, neutrophils, T cells and B cells, as evidenced by immunohistochemical analysis.5 Recent RNA-sequencing analyses have highlighted that AH is associated with the upregulation of numerous inflammatory mediators, including pro-inflammatory cytokines, chemokines and adhesion molecules.5–7 However, the key mechanisms that drive the transition from ALD to sAH remain unclear.